Take Away Food Allergy; Inducing Tolerance in Children Allergic to Peanut

NCT02457416 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2016-05-04

No results posted yet for this study

Summary

The purpose of the study is to identify prognostic markers and possible success rate of tolerance induction to peanut allergens in children allergic to peanut.

Conditions

  • Food Hypersensitivity

Interventions

OTHER

Peanut

Treatment with peanut in increasing doses until a maintenance dose

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Geir Håland, MD PhD · Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02457416 on ClinicalTrials.gov